The Fund Grade · free · no account needed
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Oakmark Select Fund Investor Class
#407 of 500 graded active funds · value · mid segment peer group
The point · specialist footprint
OAKLX puts less of its book behind proven specialists than 93% of graded funds.
● Bottom 20%
Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
OAKLX vs the Honor Roll · share card ↗Conviction exposure
0%
of the book in specialist-converged names
Late-stage weight
8.1%
of the book in Crowded or Fading names
Active share
99%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
Oakmark Select scores an F, ranking 407 of 500 graded funds, with zero specialist backing at any weight. Specialists are actively leaving GOOGL and ALLY, which together make up over 7% of the fund. LAD, TRGP, and PSX show early conviction signals, but that alone cannot offset the broader weakness here.
→ Watch ALLY closely, as specialists are fading from a 3.1% position that could weigh on returns.
→ Three higher graded funds exist in the same segment and may offer stronger specialist backing worth comparing.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.